在纽约市的夜总会与会者中纳洛的接受度
Nina Abukahok1,2, Patricia Acosta3, Amanda M Bunting3
1Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA. nina.abukahok@nyulangone.org.
Journal of community health
|March 17, 2025
概括
纳洛 (纳洛) 套件对于逆转阿片类药物过量服用至关重要,尤其是芬太尼. 许多夜总会的参与者愿意接受套装,但缺乏兴趣和知识是障碍.
科学领域:
- 公共卫生 公共卫生
- 紧急医疗 紧急医疗
- 药理学 药理学是指药理学的学科.
背景情况:
- 持续的阿片类药物危机,越来越多地由芬太尼驱动,需要有效的过量逆转策略.
- 纳洛是扭转阿片类药物过量使用的关键干预措施,强调需要了解公众愿意接受它.
- 面临非故意芬太尼暴露风险的人群需要进一步研究纳洛的接受性.
研究的目的:
- 评估面临芬太尼暴露风险的成年人是否愿意接受纳洛套件.
- 检查纳洛接受率的流行情况,并确定被调查人群中拒绝的原因.
- 为了确定与纳洛套件的接受相关的相关值.
主要方法:
- 在2024年,从随机选择的纽约市夜总会招募的991名成年人中进行了一项调查.
- 参与者被问及他们对纳洛的熟悉程度,接受套装的意愿以及拒绝的原因.
- 统计分析检查了纳洛接受的流行率和相关值,包括人口因素和准备干预.
主要成果:
- 62.1%的参与者同意接受纳洛套件,49.6%的人接受了.
- 纳洛的接受度在纽约市居民,那些熟悉纳洛的人,以及那些更愿意干预过量剂量的个人中更高.
- 拒绝的主要原因包括缺乏兴趣 (56.1%),不担心过量服用 (10.1%),已经拥有纳洛 (8.2%).
- 虽然大多数人知道纳洛可以逆转阿片类药物过量服用,但很大一部分 (35.4%) 错误地认为它可以逆转其他药物的效果.
结论:
- 接受调查的夜总会与会者中,至少有一半愿意接受纳洛套装,这表明增加访问的可能性.
- 对纳洛的功能缺乏兴趣和知识不足,是接受和携带试剂盒的重大障碍.
- 有针对性的教育和宣传可能是必要的,以克服误解,并增加在风险人群中纳洛吸收.
相关概念视频
CNS Depressants: Alcohol and Nicotine
166
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
166
Opioid Analgesics: Synthetic and Semisynthetic Opioids
201
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
201
Opioid Receptors: Overview
415
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
415
Drug Delivery: Enteral Route
360
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
360
Analgesia and Pain Management
419
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
419
Drug Abuse and Addiction: Pharmacological Phenomena
420
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
420


